The kinetics of islet amyloid polypeptide phase-separated system and hydrogel formation are critically influenced by macromolecular crowding.


Journal

The Biochemical journal
ISSN: 1470-8728
Titre abrégé: Biochem J
Pays: England
ID NLM: 2984726R

Informations de publication

Date de publication:
13 08 2021
Historique:
received: 26 05 2021
revised: 19 07 2021
accepted: 26 07 2021
pubmed: 28 7 2021
medline: 30 11 2021
entrez: 27 7 2021
Statut: ppublish

Résumé

Many protein misfolding diseases (e.g. type II diabetes and Alzheimer's disease) are characterised by amyloid deposition. Human islet amyloid polypeptide (hIAPP, involved in type II diabetes) spontaneously undergoes liquid-liquid phase separation (LLPS) and a kinetically complex hydrogelation, both catalysed by hydrophobic-hydrophilic interfaces (e.g. air-water interface and/or phospholipids-water interfaces). Gelation of hIAPP phase-separated liquid droplets initiates amyloid aggregation and the formation of clusters of interconnected aggregates, which grow and fuse to eventually percolate the whole system. Droplet maturation into irreversible hydrogels via amyloid aggregation is thought to be behind the pathology of several diseases. Biological fluids contain a high volume fraction of macromolecules, leading to macromolecular crowding. Despite crowding agent addition in in vitro studies playing a significant role in changing protein phase diagrams, the mechanism underlying enhanced LLPS, and the effect(s) on stages beyond LLPS remain poorly or not characterised.We investigated the effect of macromolecular crowding and increased viscosity on the kinetics of hIAPP hydrogelation using rheology and the evolution of the system beyond LLPS by microscopy. We demonstrate that increased viscosity exacerbated the kinetic variability of hydrogelation and of the phase separated-aggregated system, whereas macromolecular crowding abolished heterogeneity. Increased viscosity also strengthened the gel meshwork and accelerated aggregate cluster fusion. In contrast, crowding either delayed cluster fusion onset (dextran) or promoted it (Ficoll). Our study highlights that an in vivo crowded environment would critically influence amyloid stages beyond LLPS and pathogenesis.

Identifiants

pubmed: 34313292
pii: 229398
doi: 10.1042/BCJ20210384
pmc: PMC8370757
doi:

Substances chimiques

Amyloid 0
Amyloidogenic Proteins 0
Dextrans 0
Hydrogels 0
Islet Amyloid Polypeptide 0
Phospholipids 0
Protein Aggregates 0
Water 059QF0KO0R
Ficoll 25702-74-3
Glycerol PDC6A3C0OX

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3025-3046

Informations de copyright

© 2021 The Author(s).

Références

Nat Commun. 2018 Nov 29;9(1):5064
pubmed: 30498217
J Biol Chem. 2009 Oct 30;284(44):30148-58
pubmed: 19748895
Sci Rep. 2016 Aug 18;6:32124
pubmed: 27535008
J Biol Chem. 1994 Nov 18;269(46):28551-4
pubmed: 7961799
Chemistry. 2002 Sep 16;8(18):4285-91
pubmed: 12298020
Biophys J. 2000 Jan;78(1):101-9
pubmed: 10620277
Biochim Biophys Acta. 2001 Nov 29;1537(3):179-203
pubmed: 11731221
Cell. 2015 Aug 27;162(5):1066-77
pubmed: 26317470
J Phys Chem B. 2011 Jun 9;115(22):7332-40
pubmed: 21563783
Nat Commun. 2018 Jul 30;9(1):2985
pubmed: 30061688
Proc Natl Acad Sci U S A. 2020 Jun 2;117(22):12050-12061
pubmed: 32414928
FEBS Lett. 2002 Mar 27;515(1-3):99-103
pubmed: 11943202
EMBO J. 2018 Apr 3;37(7):
pubmed: 29472250
FEBS Lett. 2013 Apr 17;587(8):1119-27
pubmed: 23337872
Science. 2018 May 25;360(6391):918-921
pubmed: 29650702
J Phys Chem B. 2009 Mar 12;113(10):3160-8
pubmed: 19260715
J Mol Recognit. 2004 Sep-Oct;17(5):456-64
pubmed: 15362105
Biochemistry. 1997 Dec 2;36(48):14845-52
pubmed: 9398206
Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):8926-31
pubmed: 18579777
Biophys J. 2012 Mar 7;102(5):1154-62
pubmed: 22404938
J Mol Biol. 1986 Jun 5;189(3):553-71
pubmed: 3783684
Proc Natl Acad Sci U S A. 2019 Sep 24;116(39):19474-19483
pubmed: 31506351
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Curr Opin Struct Biol. 2000 Feb;10(1):34-9
pubmed: 10679465
Biochim Biophys Acta. 2010 Apr;1804(4):986-95
pubmed: 20100601
Biochemistry. 2008 Aug 26;47(34):8993-9006
pubmed: 18665616
Biomaterials. 2009 Dec;30(36):6814-24
pubmed: 19796805
Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5154-9
pubmed: 12700355
Biophys J. 2010 May 19;98(10):2299-308
pubmed: 20483339
Biochemistry. 2008 Apr 22;47(16):4597-605
pubmed: 18370402
Cell. 2015 Sep 24;163(1):123-33
pubmed: 26406374
Biochim Biophys Acta. 2008 Mar;1784(3):472-80
pubmed: 18252208
Protein Sci. 2005 Jul;14(7):1753-9
pubmed: 15937275
Cell. 2012 May 11;149(4):753-67
pubmed: 22579281
J R Soc Interface. 2012 Nov 7;9(76):3118-28
pubmed: 22787008
Biophys J. 1995 Aug;69(2):640-51
pubmed: 8527678
J Biol Chem. 2011 May 6;286(18):15955-63
pubmed: 21454575
FASEB J. 2010 Jan;24(1):309-17
pubmed: 19741169
Curr Opin Struct Biol. 2001 Feb;11(1):114-9
pubmed: 11179900
Proc Natl Acad Sci U S A. 2014 May 27;111(21):7671-6
pubmed: 24817693
PLoS One. 2013 Jul 29;8(7):e69652
pubmed: 23922768
Biochem J. 2013 Nov 15;456(1):67-80
pubmed: 24015785
Cell. 1982 Sep;30(2):345-7
pubmed: 6754085
J Biol Chem. 2005 Apr 29;280(17):17294-300
pubmed: 15722360
Biomolecules. 2019 Feb 19;9(2):
pubmed: 30791483
Lab Invest. 2004 Apr;84(4):523-9
pubmed: 14767490
Phys Rev Lett. 2005 Oct 14;95(16):164503
pubmed: 16241805
J Biol Chem. 2004 Nov 5;279(45):46363-6
pubmed: 15385542
J Mol Med (Berl). 2003 Nov;81(11):678-99
pubmed: 12942175
PLoS One. 2011 Jan 10;6(1):e15608
pubmed: 21249221
Biophys J. 2007 Nov 1;93(9):3132-41
pubmed: 17660321
Nature. 2013 Mar 28;495(7442):467-73
pubmed: 23455423
J Biol Chem. 2002 Mar 8;277(10):7824-30
pubmed: 11751863
Proc Natl Acad Sci U S A. 2008 Apr 22;105(16):6033-8
pubmed: 18408164
Cell Rep. 2018 Jan 2;22(1):59-71
pubmed: 29298433
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):7942-7
pubmed: 9223292
Annu Rev Biophys. 2008;37:375-97
pubmed: 18573087
J Biol Chem. 2012 Nov 2;287(45):38006-19
pubmed: 22988239
Neuron. 2015 Nov 18;88(4):678-90
pubmed: 26526393
Nat Commun. 2017 Aug 17;8(1):275
pubmed: 28819146
Langmuir. 2010 Feb 2;26(3):1424-6
pubmed: 19916492

Auteurs

Lior Pytowski (L)

Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, U.K.

David J Vaux (DJ)

Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, U.K.

Létitia Jean (L)

Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, U.K.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH